- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Tech Transfer
PINCUS: State needs better life sciences startup ecosystem
May 18, 2013
Jack Pincus / Special to IBJIndiana’s life sciences sector is mostly composed of legacy companies.
MorePurdue ends $100M deal with research foundation
April 27, 2012
Associated PressPurdue University has ended its dealings with a foundation that pledged a $100 million donation five years ago to help the
school find commercial uses for its research.
MorePurdue hopes center simplifies commercialization
January 30, 2012
J.K. WallPurdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help
developing their research into products and for outside investors to find out what research is taking place there.
MorePurdue courts Silicon Valley partnerships
November 26, 2011
Chris O'MalleyThe office, at NASA Ames Research Center, in Mountain View, Calif., aims to commercialize Purdue-developed technology through
partnerships with private industry.
MoreRoche wins as high court limits university patent rights
June 6, 2011
Bloomberg NewsMonday's Supreme Court decision is a victory for companies that collaborate with universities in research. Indianapolis-based
Eli Lilly and Co. was among the companies that supported Roche.
MorePurdue case highlights costs of defending intellectual property
March 12, 2011
J.K. WallA complicated legal case about trade secrets points up a down side to the success Indiana’s research universities have
had turning their research into revenue: Large legal bills can eat much of the money.
MoreFormer IU tech-transfer chief: State isn't competitive enough
October 30, 2010
Norm HeikensMark Long was president of the Indiana University Research & Technology Corp., which was responsible for the university’s
tech transfer, before launching a consulting firm, Long Performance Advisors, in 2008.
MoreEndocyte's $86M IPO plan a boon for Indiana, investors
August 28, 2010
Greg AndrewsVenture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
MoreIndiana universities offer cash incentives for technology transfer
August 7, 2010
IBJ StaffThe Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.
MoreIU targets tech-transfer gap
May 15, 2010
Kathleen McLaughlinIndiana University is showing signs that it's finally serious about translating research into commercial product, through
grants it is awarding via its $10 million Innovate Indiana Fund and by developing a computing technology mini-campus.
MoreAriad loses $65M patent appeal against Eli Lilly
March 22, 2010
Bloomberg NewsMonday's decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly's osteoporosis
drug Evista and sepsis medicine Xigris.
MoreMedical device developer receives $1M in federal funding
September 10, 2009
Scott OlsonIndianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
MoreRon Henriksen has accumulated a lifetime of mergers and acquisitions
August 17, 2009
Marc D. AllanA light touch and an eye for detail have brought Ron Henriksen riches and adventure in a humble life of deal-making. And at
age 70, he has no plans to stop.
MoreEmerging life sciences companies grabbing more in government grants
August 10, 2009
Chris O'MalleyMore emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
MoreLinking specialties is key to life sciences
March 30, 2009
The Indiana Innovation Alliance will bring together researchers from both IU and Purdue and keep much intellectual property
innovation in Indiana.
MoreIUPUI startup eyes yeast as fuel for ethanol
January 5, 2009
Chris O'MalleyA firm hatched out of the Indiana University School of
Medicine has raised $150,000 toward bringing to market yeasts that could be a cure for one of the biggest bioengineering challenges
of the day.
MoreSponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Three Magi
Cats out of the bag. The object of the game is to get acquired. That means the company has no idea how to grow beyond a certain point. Email is a 1990s technology. I have laughed at this company since day one. Such a small bit player. If it was anywhere but here, it wouldn't be newsworthy.
Esther, Indy has passed Chicago in the local government corruption arena. Don't downgrade us. We're No. 1 in the Midwest.
Does the buyer get to keep the recent Accu-Chek J.D. Power award? Be careful, those Swiss cannot be trusted. Last June they pimped Mayor Ballard and former Governor Daniels at a media op, announcing plans to invest "$300 million at its Indianapolis headquarters, creating up to 100 new jobs by 2017," only to turn around and close the Roche Nutley, NJ facility and eliminate 1000 jobs there later the same week. It seems that healthcare can be innovated only as long as money is to be made. Right now Roche seems to have big eyes for China: there are many Chinese in China and potential billions in Swiss francs! Since Roche is having difficulty with US insurance companies swallowing the bill for overpriced cancer drugs (with debatable efficacy) why not sell insurance to the Chinese and market the drugs to them there? There is a name for these sort of business practices however proper decorum precludes it use in this forum.
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.